March 18, 2008

Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.

4

March 18, 2008

10/969,105

October 20, 2004

514/387   548/302.7

A61K   31/4166   (20060101)   C07D   235/02   (20060101)   C07D   403/02   (20060101)  

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a divisional of U.S. application Ser. No. 10/686,073, filed Oct. 15, 2003 now U.S. Pat. No. 6,844,360, which claims the benefit of U.S. Provisional Application Ser. No. 60/422,446, filed Oct. 30, 2002, and said applications are herein incorporated by reference.

514/387   548/302.7  

7589115 - Derivatives of [6,7-dihydro-5H-imidazo[1,2-.alpha.]imidazole-3-sulfonylamino]-propionami- de - Owned by Boehringer Ingelheim Pharmaceuticals, Inc. (Ridgefield, CT) Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment of inflammatory disease.